Therapy News and Research

RSS

NCCN ORP funds researchers to evaluate targeted treatment in EGFRm+ non-small cell lung cancer

The National Comprehensive Cancer Network Oncology Research Program has funded two investigators from NCCN Member Institutions through a collaborative scientific research relationship with AstraZeneca to further evaluate the clinical effectiveness of osimertinib in the treatment of epidermal growth factor receptor-positive (EGFRm+) non-small cell lung cancer (NSCLC).

25 May 2017

Study unravels mystery of how nerve cells are damaged in neurodegenerative diseases

A new study has uncovered a molecular mechanism in the prion protein, a protein responsible for neurodegenerative diseases, which may explain why nerve cells degenerate in these disorders.

25 May 2017

Triple combination of ineffective antibiotics provides new weapon to fight against super bacteria

In the fight against super bacteria, University at Buffalo scientists are relying on strength in numbers to win the battle against drug resistance.

25 May 2017

Cluster headaches: searching for effective therapies

Cluster headaches are probably the most painful types of pain a human can suffer and it is for no small reason that this condition is also sometimes referred to as suicide headache.

25 May 2017

BGU researchers redesign portion of FDA-approved drug into new molecule to treat ALS

Ben-Gurion University of the Negev researchers are developing a new therapy for Amyotrophic Lateral Sclerosis using part of an existing FDA-approved drug that restores the central nervous system's (CNS) immune defenses and increases life expectancy.

25 May 2017

Stem cell therapy using Helix transendocardial delivery system provides better results, study shows

BioCardia, Inc. today announced publication of a study in the International Heart Journal. According to the study, delivery of stem cell therapy to the heart using the Helix transendocardial delivery system results in superior cell delivery than either percutaneous intra-coronary infusion or direct injection in an open chest procedure.

24 May 2017

Feinstein Institute honors Sir Paul Nurse with Cerami Award for cancer research

Northwell Health's Feinstein Institute for Medical Research and Molecular Medicine announced today that the seventh Anthony Cerami Award in Translational Medicine will be awarded to Sir Paul Nurse, PhD, director of The Francis Crick Institute.

24 May 2017

Cognitive behavioral therapy can help cure many common phobias

Everyone fears something. In fact, it is estimated that more than 19 million Americans suffer from specific phobia.

24 May 2017

Researchers develop new modified toy car designs for children with disabilities

Researchers at Oregon State University have developed two new modified toy car designs for children with disabilities in an effort to encourage them to further explore, play, and engage in physical and social activities.

24 May 2017

Biochemists create new tool to help diagnose POLG disorders and predict outcomes

Providing answers -- or at least more information -- to the most difficult medical questions is the aim of medical scientists. And how research findings are translated and made available can be as important as the discoveries themselves.

24 May 2017

Researchers present promising approach to create virus- and oncogene-free IPSCs

Induced pluripotent stem cells (IPSCs) hold great promise in regenerative medicine, personalized medicine and drug discovery.

24 May 2017

New test could help physicians identify appropriate treatment for people with gonorrhea

Researchers from UCLA have developed a laboratory test that helps physicians determine which people with gonorrhea may be more treatable with an antibiotic that has not been recommended since 2007 because of concerns that the resistance to the drug was growing.

24 May 2017

NUS scientists develop novel handheld device for treatment of 'glue ear' in children

A team of researchers from the National University of Singapore has developed a novel handheld device, known as CLiKX, for the treatment of a condition called Otitis Media with Effusion, or 'glue ear', which is the leading cause of hearing loss and visits to the doctors among children worldwide.

24 May 2017

New study offers insight into how to improve chemotherapy strategies for ovarian cancer

Most women diagnosed with ovarian cancer undergo surgery to remove as many of the tumors as possible. However, it is usually impossible to eliminate all of the cancer cells because they have spread throughout the abdomen. Surgery is therefore followed by 18 weeks of chemotherapy.

24 May 2017

Study points to new pharmacologic approach to target chemo-resistant lung cancer

Patients with non-small cell lung cancer (NSCLC) often respond to standard chemotherapy, only to develop drug resistance later, and with fatal consequences.

23 May 2017

Pupil dilation could help predict depression risk following disaster-related stress

Pupil dilation could identify which individuals are at greatest risk for depression following disaster-related stress, and help lead to targeted interventions, according to new research from Binghamton University, State University of New York.

23 May 2017

Seattle Children’s opens first clinical trial to study IBD and GVHD in pediatric patients

In an effort to find new strategies to personalize treatment for pediatric patients, Seattle Children's has opened the first clinical trial applying next-generation T-cell receptor sequencing and single-cell gene expression analysis to better understand how the immune system drives both inflammatory bowel disease in pediatric autoimmunity patients and graft-versus host disease in pediatric bone marrow transplant patients.

From 10x Genomics, Inc. 23 May 2017

Study: Abnormal proteins in Alzheimer's, Parkinson's, and Huntington's diseases share similar feature

A Loyola University Chicago study has found that abnormal proteins found in Alzheimer's disease, Parkinson's disease, and Huntington's disease all share a similar ability to cause damage when they invade brain cells.

23 May 2017

Study finds 22% antibiotic failure rate in pneumonia treatment

The new study presented at the 2017 American Thoracic Society International Conference has found that about 22.1%, approximately one in four adults, failed to respond to antibiotics for community-acquired pneumonia (CAP) treatment.

23 May 2017

VCU study provides new view about HPV-related head and neck cancers

Much of what we thought we knew about the human papilloma virus (HPV) in HPV-related head and neck cancers may be wrong, according to a newly published study by Virginia Commonwealth University researchers that analyzed data from The Human Cancer Genome Atlas.

23 May 2017

Therapy News and Research

NCCN ORP funds researchers to evaluate targeted treatment in EGFRm+ non-small cell lung cancer

Study unravels mystery of how nerve cells are damaged in neurodegenerative diseases

Triple combination of ineffective antibiotics provides new weapon to fight against super bacteria

Cluster headaches: searching for effective therapies

BGU researchers redesign portion of FDA-approved drug into new molecule to treat ALS

Stem cell therapy using Helix transendocardial delivery system provides better results, study shows

Feinstein Institute honors Sir Paul Nurse with Cerami Award for cancer research

Cognitive behavioral therapy can help cure many common phobias

Researchers develop new modified toy car designs for children with disabilities

Biochemists create new tool to help diagnose POLG disorders and predict outcomes

Researchers present promising approach to create virus- and oncogene-free IPSCs

New test could help physicians identify appropriate treatment for people with gonorrhea

NUS scientists develop novel handheld device for treatment of 'glue ear' in children

New study offers insight into how to improve chemotherapy strategies for ovarian cancer

Study points to new pharmacologic approach to target chemo-resistant lung cancer

Pupil dilation could help predict depression risk following disaster-related stress

Seattle Children’s opens first clinical trial to study IBD and GVHD in pediatric patients

Study: Abnormal proteins in Alzheimer's, Parkinson's, and Huntington's diseases share similar feature

Study finds 22% antibiotic failure rate in pneumonia treatment

VCU study provides new view about HPV-related head and neck cancers

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News